NEW YORK, Dec. 15 (GenomeWeb News) - TriLink Bio Technologies has received an STTR Phase II funding from the National Institutes of Health to continue collaborating on the structure-free DNA and RNA program, the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.
Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.
The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.
In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.